Summarize This Guide with AI
The page title, key topics and source link are passed to your selected tool in a prepared prompt.
On this page
When a penile filler procedure is described as Androfill, the name does not by itself identify the gel being injected. Androfill describes an approach to placing hyaluronic acid, or HA, around the penile shaft to increase its circumference. The actual product has a separate commercial name, which should be discussed before deciding on any procedure.
Two providers may both use HA while describing different placement methods and follow-up arrangements. To understand the offer, separate the technique description from the properties of the product and from clinical studies of outcomes. Evidence about HA in general does not automatically establish the results of a named protocol.
Androfill and UroFill describe different approaches
In Androfill’s public patient explanation, HA gel is placed beneath the shaft skin with a blunt cannula, a narrow tube used to deliver the filler. The procedure described concerns shaft girth. It does not place filler inside the erectile bodies to create additional erect length.
The published UroFill method describes defining a tissue space with fluid, known as hydrodissection, between the Dartos and Buck fascial layers before placing HA. The European Patent Office document describes that method. A technical document can explain the intended steps; it does not establish clinical superiority.
These are separate named approaches that use the same broad filler material. The publicly available detail in Androfill’s description is insufficient to verify every step of both protocols side by side. It would also be inaccurate to say that only one can involve staged treatment: both describe reassessment and possible later additions.
The publications reviewed for this guide did not provide a direct clinical comparison of Androfill against UroFill. They therefore cannot establish which lasts longer or produces fewer complications. The separate UroFill technique guide discusses its published series without treating those findings as a comparison trial.
What is assessed before a procedure
The starting point is the change someone wants in the shaft, together with the existing contour and relevant medical history. Previous filler, surgery or a new shape change can alter the assessment. Bring any available record of earlier products rather than relying only on the name a previous provider used.
New curvature, pain, erection difficulty or apparent loss of length needs its own explanation before additional filler is considered. A firm area following an earlier injection may reflect a different problem from a naturally uneven contour. Adding material before understanding it can leave the original concern unaddressed.
The EAU guideline on penile size concerns also includes psychological assessment when body dysmorphic disorder is suspected. Persistent measuring or intense preoccupation despite ordinary measurements can matter as much as a centimetre value. That discussion helps determine whether an intervention would address the actual source of distress.
Shaft filler targets circumference. Erect length is a different measurement, and glans filler concerns a separate anatomical area. If the word enlargement is used in a consultation, clarify which area and which measurement are being discussed. A girth procedure should not be presented as treatment for erectile dysfunction.
Questions about the product and follow-up
Ask for the exact product name, how baseline circumference will be recorded and what the first review is intended to assess. The Androfill name cannot specify your personal result or follow-up date. The clinician’s explanation should connect the plan to the findings of examination.
If a procedure goes ahead, keep the product label or record containing its name and batch number. This can be useful if you later need a review elsewhere. Tell the clinician about previous procedures in the area, including any earlier complication or treatment to reduce filler.
Measurement is more useful when the same shaft location and physical state are compared over time. Photographs taken with different lighting, angle or erection state cannot reliably establish a centimetre change. Early swelling can also exaggerate the initial appearance. The filler recovery guide explains why an immediate photograph is not the final assessment.
Instead of treating a requested millilitre amount as a prescription, ask how the proposed volume was chosen for you. Starting circumference alone cannot determine that volume. The guide to penile filler amounts discusses the role of anatomy, previous treatment and examination rather than offering a dose calculation.
How long the change may last
HA can break down over time. The name of a technique cannot promise a fixed number of months. The gel, tissue response and follow-up conditions can affect what remains visible or measurable. A claim about eighteen months may refer to a study visit, a provider’s expectation or an actual measured change; those are different kinds of information.
In Yang and colleagues’ randomised comparison, 67 participants received HA or polylactic acid filler and 46 were followed to eighteen months. In the HA group, mean flaccid circumference increases were 2.50 cm at one month, 1.91 cm at six months and 1.41 cm at eighteen months. This was not a study of Androfill.
The researchers measured the flaccid shaft at three locations and averaged those measurements. A study using one location or an erect measurement cannot simply be compared as if the method were identical. The eighteen-month group average does not mean that every participant retained that change or that everyone’s effect ended at that visit.
UroFill-specific findings include conference abstracts, which have their own reporting limitations. They cannot substitute for an Androfill comparison study. The EAU addresses HA among girth-enhancement options with a weak recommendation and identifies limitations in the evidence. A technique description or a favourable photograph does not remove those limitations.
Changes after treatment that need review
Seek prompt medical assessment for increasing pain, pronounced pallor or darkening of the skin, rapidly worsening swelling, discharge or fever. Difficulty passing urine also requires early assessment. Mild swelling or bruising can occur initially, but the direction of change and accompanying symptoms matter. Do not wait for an ordinary review appointment if symptoms are progressing.
Androfill’s aftercare information describes warning signs and a follow-up process. Instructions given for a particular product and procedure should come from the treating clinician. Reading a public protocol is not a reason to start forceful massage or try to shift a new lump yourself.
In Quan and colleagues’ retrospective study, 230 men were followed for six months after HA penile augmentation. Subcutaneous bleeding, nodules and infection were reported. The procedure was not identified as Androfill, so its results cannot provide an Androfill-specific risk rate. It does show why follow-up should include more than a size measurement.
HA may move or accumulate unevenly, while swelling can initially create a similar appearance. Explain when a change began and whether pain, discolouration or discharge is present. The clinician needs to determine the cause before deciding whether observation or another intervention is appropriate.
Hyaluronidase can be considered by a clinician to reduce confirmed HA in selected circumstances. It is not a universal answer to every hard area, infection or tissue problem. An infected lump needs a different assessment from uncomplicated uneven gel distribution, and non-HA material cannot be assumed to respond in the same way.
Before choosing any penile filler procedure, clarify who will review a concern after treatment and how to reach them. Bring earlier product records to the consultation and ask what the proposed method can reasonably change in your own anatomy.
Sources8 sources
Androfill
Androfill uygulama protokolüUroFill
UroFill uygulama protokolü hakkında sık sorulan sorularEuropean Patent Office
System and method for nonsurgical penile girth enhancementAndrofill
Androfill işlem sonrası takip bilgileriEuropean Association of Urology
EAU Guidelines on Sexual and Reproductive Health — Penile Size Abnormalities and DysmorphophobiaYang DY, Jeong HC, Ko K, Lee SH, Lee YG, Lee WK · Journal of Clinical Medicine · 2020
Comparison of Clinical Outcomes between Hyaluronic and Polylactic Acid Filler Injections for Penile Augmentation in Men Reporting a Small PenisDOI: 10.3390/jcm9041024PubMed: 32260508
Quan Y, Gao ZR, Dai X, et al. · Asian Journal of Andrology · 2021
Complications and management of penile augmentation with hyaluronic acid injectionDOI: 10.4103/aja.aja_78_20PubMed: 33533738
Suarez-Sarmiento A Jr, Perito P, Cisneros JB, Levitt B, Pomar HA · The Journal of Sexual Medicine, kongre bildirisi · 2024
Safety and Efficacy of Hyaluronic Acid Injections Using the UroFill Technique for Penile Girth EnhancementDOI: 10.1093/jsxmed/qdae001.046
